NASDAQ: DCXDigital Currency X Technology Inc Stock
$2.42-0.04 (-1.63%)
Updated May 28, 2026
DCX Price
$2.42
Fair Value Price
$1.69
Market Cap
$50.97M
52 Week Low
$1.43
52 Week High
$3,432.00
P/E
-0.57x
P/B
0.34x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$3.61M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
4.7
Operating Cash Flow
-$55M
Beta
0.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
DCX Overview
Jupiter Wellness Acquisition Corporation is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the healthcare industry. Jupiter Wellness Acquisitionwas incorporated in 2021 and is based in Jupiter, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine DCX's potential to beat the market
- DCX doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Auto
Industry Rating
F
DCX
RankedUnranked of 22
RankedUnranked of 22
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $84.35 | B | |
| $70.19 | B | |
| $16.65 | C |
Be the first to know about important DCX news, forecast changes, insider trades & much more!
DCX News
Overview
Due Diligence Score
–
Industry Average (22)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DCX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DCX ($2.42) is overvalued by 43.51% relative to our estimate of its Fair Value price of $1.69 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
DCX ($2.42) is not significantly undervalued (43.51%) relative to our estimate of its Fair Value price of $1.69 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
DCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DCX due diligence checks available for Premium users.
Valuation
DCX fair value
Fair Value of DCX stock based on Discounted Cash Flow (DCF)
Price
$2.42
Fair Value
$1.69
Overvalued by
43.51%
DCX ($2.42) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DCX ($2.42) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DCX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DCX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.57x
Industry
271.31x
Market
23.04x
DCX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.34x
Industry
3.79x
DCX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DCX's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
DCX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$866.7M
Liabilities
$709.2M
Debt to equity
4.7
DCX's short-term assets ($866.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DCX's short-term assets ($866.68M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DCX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
DCX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
DCX vs Auto Stocks
Digital Currency X Technology Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.